What Researchers Did
Researchers conducted a randomized controlled trial involving 24 patients with head and neck squamous cell carcinoma to compare radiotherapy in hyperbaric oxygen versus air.
What They Found
The study found a significant gain in local control (P less than 0.001) and survival (P less than 0.05) for patients receiving radiotherapy in hyperbaric oxygen. Importantly, there was no increased tissue reactions or morbidity observed with this approach.
What This Means for Canadian Patients
Canadian patients with head and neck cancer might experience improved local control and survival outcomes if hyperbaric oxygen is used during their radiotherapy. This approach could potentially offer better treatment efficacy without increasing side effects.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A significant limitation of this study is the very small number of patients included in the analysis.